Anders Bjartell

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Kim N., Neeraj Agarwal, Anders Bjartell et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

Meelan Bul, Xiaoye Zhu, R. Valdagni et al. · European Urology · 2012 · 542 citations

Medicine, Oncology, Urology +16

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

Kim N., Simon Chowdhury, Anders Bjartell et al. · Journal of Clinical Oncology · 2021 · 508 citations · Full text

Medicine, Oncology, Pharmacology +16

Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

Eva Haglind, Stefan Carlsson, Johan Stranne et al. · European Urology · 2015 · 491 citations · Full text

Medicine, Surgery, Urology +17

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf et al. · European Urology · 2016 · 419 citations · Full text

Medicine, Oncology, Pharmacology +13